CMS Update on Coronavirus Assay

CMS has authorized, for emergency use, a non-FDA approved CDC 2019-Novel Coronavirus (2019-nCoV) [renamed Covid-19 by WHO] Real-Time RT-PCR Diagnostic Panel Assay and Guidance for Authorized Laboratories.

To view CMS's February 6, 2020, Memo (QSO 20-10-CLIA) to CLIA surveyors, click here.

We will forward additional information as it becomes available.